Features of interleukin status in patients with type 1 diabetes mellitus
HERALD of North-Western State Medical University named after I.I. Mechnikov · 2022
DOI: 10.17816/mechnikov107281 ↗Kurz gefasst
Fachartikel in der Zeitschrift HERALD of North-Western State Medical University named after I.I. Mechnikov, 2022. Verfasst von Mikhail E. Mailyan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
A hundred years have passed since the first use of insulin as the main means of therapy for type 1 diabetes mellitus. During this time, significant progress has been made in the development of insulin therapy, including the development of new insulin formulations and methods of its delivery. At the same time, over the years, expanding knowledge about the immunopathogenesis of type 1 diabetes mellitus, doctors are trying to reach a completely new level of possibilities in the treatment of this disease. At this level, methods of immunotherapeutic effects on those links of autoimmune chains will become available, which today limit both the therapy of patients with type 1 diabetes and the development of the idea of stem-cells transplantation due to the lack of a holistic understanding of ways to overcome post-transplant immune aggression against -cells. The review summarizes the current understanding of known interleukins involved as the most important intermediaries in the phases of initiation and immuno-mediated destruction of pancreatic -cells. The achievements in the study of the role of key interleukins in the pathophysiology of autoimmune diabetes for marking potential application points of immunomodulatory targeted therapy are considered.
Zitieren
APA
Mailyan, M. E., Pugachev, M. I., Shustov, S. B., Salukhov, V. V., & Livarsky, P. A. (2022). Features of interleukin status in patients with type 1 diabetes mellitus. HERALD of North-Western State Medical University named after I.I. Mechnikov. https://doi.org/10.17816/mechnikov107281
Vancouver
Mailyan ME, Pugachev MI, Shustov SB, Salukhov VV, Livarsky PA. Features of interleukin status in patients with type 1 diabetes mellitus. HERALD of North-Western State Medical University named after I.I. Mechnikov. 2022. doi:10.17816/mechnikov107281
BibTeX
@article{Mailyan2022,
author = {Mailyan, Mikhail E. and Pugachev, Maksim I. and Shustov, Sergey B. and Salukhov, Vladimir V. and Livarsky, Pavel A.},
title = {Features of interleukin status in patients with type 1 diabetes mellitus},
journal = {HERALD of North-Western State Medical University named after I.I. Mechnikov},
year = {2022},
doi = {10.17816/mechnikov107281}
}
EUVIMED